UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy

The Journal of molecular diagnostics : JMD, 2019-07, Vol.21 (4), p.553-571

2019

Volltextzugriff (PDF)

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.1474-1482

2018

Volltextzugriff (PDF)

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

Journal of thoracic oncology, 2016-03, Vol.11 (3), p.414-419

2016

Volltextzugriff (PDF)

Epithelioid GBMs show a high percentage of BRAF V600E mutation

The American journal of surgical pathology, 2013-05, Vol.37 (5), p.685-698

2013

Volltextzugriff (PDF)

Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis

Journal of thoracic oncology, 2016-08, Vol.11 (8), p.1293-1304

2016

Volltextzugriff (PDF)

DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer

Journal of thoracic oncology, 2019-04, Vol.14 (4), p.737-741

2019

Volltextzugriff (PDF)

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

Journal of thoracic oncology, 2019-09, Vol.14 (9), p.1666-1671

2019

Volltextzugriff (PDF)

Resistance Mechanisms to Targeted Therapies in ROS1 + and ALK + Non-small Cell Lung Cancer

Clinical cancer research, 2018-07, Vol.24 (14), p.3334-3347

2018

Volltextzugriff (PDF)

Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-04, Vol.372 (18), p.1700-1709

2015

Volltextzugriff (PDF)

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

Journal of thoracic oncology, 2012-12, Vol.7 (12), p.1807-1814

2012

Volltextzugriff (PDF)

Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non-Small Cell Lung Cancer

Clinical cancer research, 2018-06, Vol.24 (12), p.2758-2770

2018

Volltextzugriff (PDF)

Identifying and Targeting ROS1 Gene Fusions in Non―Small Cell Lung Cancer

Clinical cancer research, 2012-09, Vol.18 (17), p.4570-4579

2012

Volltextzugriff (PDF)

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Journal of thoracic oncology, 2015-05, Vol.10 (5), p.768-777

2015

Volltextzugriff (PDF)

Targeting the WNT Signaling Pathway in Cancer Therapeutics

The oncologist (Dayton, Ohio), 2015-10, Vol.20 (10), p.1189-1198

2015

Volltextzugriff (PDF)

Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer

PloS one, 2013-12, Vol.8 (12), p.e82236

2013

Volltextzugriff (PDF)

Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer

Cancer, 2012-09, Vol.118 (18), p.4502-4511

2012

Volltextzugriff (PDF)

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2018-02, Vol.142 (2), p.253-262

2018

Volltextzugriff (PDF)

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation

The American journal of surgical pathology, 2015-04, Vol.39 (4), p.528-540

2015

Volltextzugriff (PDF)

Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2017-07, Vol.12 (7), p.e85-e88

2017

Volltextzugriff (PDF)

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2016-04, Vol.140 (4), p.341-344

2016

Volltextzugriff (PDF)

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

Journal of thoracic oncology, 2016-08, Vol.11 (8), p.1273-1281

2016

Volltextzugriff (PDF)

EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13), p.3551-3563

2017

Volltextzugriff (PDF)

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2016-11, Vol.140 (11), p.1267-1272

2016

Volltextzugriff (PDF)

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society

Archives of pathology & laboratory medicine (1976), 2018-03, Vol.142 (3), p.408-419

2018

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Englisch
(174)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Life Sciences & Biomedicine
(106)
Humans
(96)
Oncology
(65)
Female
(42)
Male
(41)
Pathology
(38)
Lung Neoplasms - Genetics
(35)
Mutation
(33)
Middle Aged
(30)
Carcinoma, Non-Small-Cell Lung - Genetics
(27)
Adult
(26)
Lung Cancer
(25)
Lung Neoplasms - Pathology
(25)
Aged
(24)
Lung Neoplasms - Drug Therapy
(24)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(20)
Carcinoma, Non-Small-Cell Lung - Pathology
(20)
Respiratory System
(20)
Protein Kinase Inhibitors - Therapeutic Use
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

Epithelioid GBMs show a high percentage of BRAF V600E mutation

Identifying the Appropriate FISH Criteria for Defining MET Copy Number–Driven Lung Adenocarcinoma through Oncogene Overlap Analysis

DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium

Resistance Mechanisms to Targeted Therapies in ROS1 + and ALK + Non-small Cell Lung Cancer

Rociletinib in EGFR-Mutated Non–Small-Cell Lung Cancer

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer

Clinical Utility of Cell-Free DNA for the Detection of ALK Fusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non-Small Cell Lung Cancer

Identifying and Targeting ROS1 Gene Fusions in Non―Small Cell Lung Cancer

Multi-institutional Oncogenic Driver Mutation Analysis in Lung Adenocarcinoma: The Lung Cancer Mutation Consortium Experience

Targeting the WNT Signaling Pathway in Cancer Therapeutics

Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer

Oncogene status predicts patterns of metastatic spread in treatment‐naive nonsmall cell lung cancer

Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation

Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non–Small Cell Lung Cancer

Programmed Death Ligand-1 Immunohistochemistry--A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer

Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors

EGFR Mediates Responses to Small-Molecule Drugs Targeting Oncogenic Fusion Kinases

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society

Suchergebnisse filtern